$MRVI Cashflow Statement | Understand Stock

$MRVI

$8.50 +$0.24 (2.91%) Close

$MRVI Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities:
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:
Depreciation
Amortization of intangible assets
Amortization of operating lease right-of-use assets
Amortization of deferred financing costs
Stock-based compensation expense
Loss on extinguishment of debt
Deferred income taxes
Gain on sale of business
Gain on sale and leaseback transaction
Acquired and in-process research and development costs
Financing costs incurred for line of credit
Goodwill impairment
Change in estimated fair value of contingent consideration
Impairment
Revaluation of liabilities under the Tax Receivable Agreement
Acquisition related tax adjustment
Other
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable
Inventory
Prepaid expenses and other current assets
Government funding receivable
Other assets
Accounts payable
Accrued expenses and other current liabilities
Deferred revenue
Other long-term liabilities

Net cash (used in) provided by operating activities
Investing activities:
Cash paid for acquisitions of a business, net of cash acquired
Acquisition deposit
Purchases of property and equipment
Proceeds from government assistance allocated to property and equipment
Prepaid lease payments on finance lease yet to commence
Proceeds from sale of building
Purchase of technology
Proceeds from sale of business, net of cash divested
Other investing activities, net
Net cash used in investing activities
Financing activities:
Proceeds from borrowings of long-term debt, net of discount
Refunds (distributions) for tax liabilities to non-controlling interests holder
Principal repayments of long-term debt
Financing costs paid to acquire long-term debt
Repurchase of incentive units
Payments of finance lease liabilities
Proceeds from interest rate cap agreement
Payments of acquisition related contingent consideration and consideration holdback
Payments pursuant to the Tax Receivable Agreement
MLSH 1
MLSH 2
Total payments pursuant to the Tax Receivable Agreement
Payment for non-controlling interests in MLSC
Payment to MLSH 2 for Blocker Mergers
Proceeds from issuance of common stock
Purchase of LLC Units from MLSH 1
Repurchase of Class A common stock from MLSH 2
(Taxes paid for shares withheld) proceeds from issuance of Class A common stock under employee equity plans, net
Other financing activities, net
Net cash used in financing activities

Effects of exchange rate changes on cash
Net decrease in cash and cash equivalents
Cash and cash equivalents, beginning of period
Cash and cash equivalents, end of period
Supplemental cash flow information:
Cash paid for interest
Cash (refunded) paid for income taxes, net
Supplemental disclosures of non-cash activities:
Property and equipment included in accounts payable and accrued expenses
Financing cost deducted from long-term debt proceeds
Accrued receivable for capital expenditures to be reimbursed under a government contract
Right-of-use assets obtained in exchange for finance lease liabilities
Right-of-use assets obtained in exchange for operating lease liabilities
Building and improvements capitalized under lease financing transaction
Property and equipment under new capital lease
Fair value of contingent consideration liability recorded in connection with acquisition of a business
Accrued consideration payable for MyChem acquisition
Exchange of units for MLSC non-controlling interests
Exchange of Class A common stock for the Blocker Mergers
Recognition of deferred tax assets as a result of exchanges of LLC Units and cash contribution
Recognition of liabilities under the Tax Receivable Agreement
IPO issuance costs included in accounts payable and accrued expenses
Receivable from lessor funded financing

Comments